Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of chronic and degenerative conditions
3.2.1.2 Growing advancement in regenerative medicine
3.2.1.3 Increasing R&D investment and activities
3.2.1.4 Growing pet ownership and spendings
3.2.2 Industry pitfalls & challenges
3.2.2.1 Adverse effects of the treatment
3.2.2.2 Regulatory challenges
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Pet population, by country
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Companion animals
5.3 Livestock animals
Chapter 6 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Stem cell therapy
6.2.1 Autologous
6.2.2 Allogeneic
6.3 Biological therapy
6.3.1 Platelet-rich plasma (PRP)
6.3.2 Growth factors
6.4 Tissue engineering
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Orthopedics
7.3 Trauma/ wound care
7.4 Other applications
Chapter 8 Market Estimates and Forecast, By End-User, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Veterinary hospitals
8.3 Veterinary clinics
8.4 Academics and research institutes
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Animal Cell Therapies, Inc.
10.2 Ardent
10.3 Bioceltix
10.4 Boehringer Ingelheim International GmbH
10.5 CTSL (Cell Therapy Sciences)
10.6 Dechra
10.7 Enso Discoveries
10.8 Magellan Stem Cells
10.9 Medrego
10.10 Regeneus Ltd (Cambium Bio Ltd.)
10.11 StemcellX
10.12 VetStem, Inc.
10.13 Zoetis Inc.
